Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis

Transplantation. 2021 Nov 1;105(11):e263-e264. doi: 10.1097/TP.0000000000003908.

Authors

Rommel Ravanan¹, Lisa Mumford, Ines Ushiro-Lumb, Chris Callaghan, Gavin Pettigrew, Douglas Thorburn, Dale Gardiner, John Forsythe; on behalf of the OTDT Clinical Team

Affiliation

¹ NHS Blood and Transplant, Filton, Bristol, United Kingdom.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / immunology
COVID-19 / mortality*
COVID-19 / prevention & control
COVID-19 / virology
COVID-19 Nucleic Acid Testing
COVID-19 Vaccines / administration & dosage*
Humans
Immunization Schedule
Mass Vaccination / statistics & numerical data
Organ Transplantation / adverse effects*
RNA, Viral / isolation & purification
Registries / statistics & numerical data
Risk Assessment / statistics & numerical data
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology
Transplant Recipients / statistics & numerical data*
United Kingdom / epidemiology

Substances

COVID-19 Vaccines
RNA, Viral